They have to live with the HIV virus. This plight concerns 35.3 million people throughout the world according to the figures released in 2012 by UNAIDS, the authority set up by the United nations to coordinate the different agencies of the UN that specialize in the fight against HIV/AIDS. There are certainly other more encouraging statistics hidden behind this figure. Indeed, Infections have decreased by 30% since 2001 and there have been around 29% fewer deaths connected with AIDS since 2005. Nevertheless, global statistics still hide large disparities, of a geographical nature in this case. Indeed the challenges are always greater in poor countries with limited resources, both in terms of access to treatment and patient care. Chatté Idékhim Adawaye’s thesis provides clarity that is both pragmatic and useful in relation to this latter point. His research focuses on a very particular situation, that of Chad, and he develops solutions that are both adapted and effective. The aim is to provide people living with HIV in this country with proper care that would make it possible to detect HIV resistance to antiretroviral drugs (ARV) and consequently, to suggest another treatment in time. To succeed in this, it is of the utmost importance that all the actors concerned become aware of the crucial issues surrounding the question of HIV resistance to ARV drugs. This is the condition under which a proper care system for patients could be organized and is an essential condition for successful treatment. There is no resistance test available in this country which requires the development of alternative methods for better epidemiological monitoring of resistance to HIV treatment.

Read the article

(1)    New genotypical approaches for the monitoring of HIV resistance to ARV drugs in countries with limited resources: the case of Chad. Doctoral thesis of Chatté Idékhim ADAWAYE completed under the supervision of Michel MOUTSCHEN, University of Liege, 2014.